Amines

Results: 4364



#Item
861Quinazolines / Tyrosine kinase receptors / Organofluorides / Amines / Organochlorides / Gefitinib / Erlotinib / Epidermal growth factor receptor / Afatinib / Chemistry / Organic chemistry / Medicine

1293 Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:25
862Glyphosate / Ammonium sulfate / Chemistry / Herbicides / Amines

Advice Summary - Product No[removed], Application No[removed]

Add to Reading List

Source URL: archive.apvma.gov.au

Language: English - Date: 2014-06-30 08:24:29
863Amines / Glyphosate / Agriculture / Roundup / Herbicides / Chemistry / Acetic acids

ADVICE SUMMARY APPLICATION FOR REGISTRATION OF A CHEMICAL PRODUCT Product name: Applicant: Product number: Application number:

Add to Reading List

Source URL: archive.apvma.gov.au

Language: English - Date: 2014-06-30 08:21:20
864Amines / Eli Lilly and Company / Ketones / Methadone / Organic chemistry / Addiction / Ethics / Chemistry / Drug rehabilitation

AUSTRALIAN CAPITAL TERRITORY Drugs of Dependence (Amendment) Act (No[removed]No. 61 of 1992

Add to Reading List

Source URL: www.legislation.act.gov.au

Language: English - Date: 2013-02-17 18:01:22
865Amines / Quinazolines / Lung cancer / Organofluorides / Alkynes / Gefitinib / Erlotinib / Epidermal growth factor receptor / Non-small-cell lung carcinoma / Chemistry / Medicine / Organic chemistry

Public Summary Document Application No. 1173 – Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for erlotinib treatment as a first line therapy in patients with locally advanced or metastat

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:40
866Quinazolines / Organofluorides / Amines / Organochlorides / Lung cancer / Gefitinib / Erlotinib / Epidermal growth factor receptor / Afatinib / Chemistry / Organic chemistry / Medicine

1293 Final Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) gene mutation testing for eligibility for afatinib treatment in patients with stage IIIB or stage IV non-sma

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:26
867Quinazolines / Amines / Organofluorides / Organochlorides / Lung cancer / Gefitinib / Erlotinib / Epidermal growth factor receptor / Non-small-cell lung carcinoma / Chemistry / Organic chemistry / Medicine

Public Summary Document Application No. 1173 – Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for a

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:40
868Quinazolines / Amines / Organofluorides / Organochlorides / Lung cancer / Gefitinib / Epidermal growth factor receptor / Erlotinib / Non-small-cell lung carcinoma / Chemistry / Organic chemistry / Medicine

Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) Sponsor/Applicant/s:

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:56
869Lung cancer / Amines / Quinazolines / Organofluorides / Alkynes / Gefitinib / Erlotinib / Non-small-cell lung carcinoma / Epidermal growth factor receptor / Medicine / Chemistry / Oncology

MSAC Application 1173: Consultation Decision Analytic Protocol (DAP) to guide the assessment of Epidermal Growth Factor Receptor (EGFR) testing for eligibility for erlotinib treatment as a first line therapy in patients

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:43
870Quinazolines / Organofluorides / Amines / Organochlorides / Lung cancer / Gefitinib / Erlotinib / Epidermal growth factor receptor / Non-small-cell lung carcinoma / Chemistry / Organic chemistry / Medicine

Public Summary Document Application No. 1161 – Gefitinib first line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC)

Add to Reading List

Source URL: www.msac.gov.au

Language: English - Date: 2014-11-06 23:49:55
UPDATE